Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

568 results

Delayed compromise of a “super dominant” RCA and Shock

14 Sep 2021

Coronary obstruction is a known procedural complication of aortic valve replacement. However, delayed presentation few months after surgical AVR is a relatively unusual phenomenon.  We describe a 75 year old woman with surgical AVR who presented with acute coronary syndrome and severe RV failure few months...

Tesfaye A. Telila

Author

Tesfaye A. Telila
Delayed compromise of a “super dominant” RCA and Shock

MASTER-DAPT: “the MASTER of high-bleeding risk trials”

28 Aug 2021

Marco Valgimigli (Lugano, Switzerland) presented the results of the MASTER DAPT trial on Saturday, August 28, in a Hot Line session of the ESC Congress 2021. Luis G. Ortega-Paz provides his PICOT & SWOT analysis of this study.

Luis Ortega-Paz

Author

Luis Ortega-Paz
ESC Congress 2021 - MASTER-DAPT : “the MASTER of high-bleeding risk trials”

MASTER DAPT: dual antiplatelet therapy after coronary stenting in high bleeding risk patients - interview with Marco Valgimigli

28 Aug 2021

ESC Congress 2021: Discover the interview given by Marco Valgimigli to Luis G. Ortega-Paz for PCRonline about the MASTER-DAPT trial to assess whether one month of dual antiplatelet therapy preserves the net and major adverse cardiovascular events.

Luis Ortega-Paz

Author

Luis Ortega-Paz
Marco Valgimigli

Author

Marco Valgimigli
ESC Congress 2021 - MASTER DAPT: dual antiplatelet therapy after coronary stenting in high bleeding risk patients

Stent expansion indexes to predict clinical outcomes: an IVUS substudy from ADAPT-DES

23 Aug 2021

The purpose of the present investigation was to revisit all stent expansion indexes to identify the best predictor of 2-year percutaneous coronary intervention (PCI) lesion-specific outcome measures (i.e. clinically-driven target lesion revascularization [TLR] or definite stent thrombosis) using the ADAPT-DES IVUS substudy cohort.

Reviewer

Salvatore Brugaletta
Stent expansion indexes to predict clinical outcomes: an IVUS substudy from ADAPT-DES

Two cases of circumflex coronary anomaly arising from RCA: one of them with inferior STEMI and VT

28 Jul 2021

The origin of circumflex from the main RCA has a reported incidence of 0.37 %. Here are two very unusual cases of an anomalous origin of the left circumflex coronary artery from the proximal RCA, one of them with inferior STEMI and VT.

Juan Guzman Olea

Author

Juan Guzman Olea

Author

Gabriel Guzmán Olea

Author

Gonzalo Tolosa Dzul

Author

Rodrigo Manzo Guzmán

Author

Daniel Iván Pérez Vásquez
Suárez Romero Suárez Romero

Author

Elizabeth Suárez Romero

Author

Antonio Fernando Real Ramírez
Two cases of circumflex coronary anomaly arising from RCA: one of them with inferior STEMI and VT

Unusual, late presentation of coronary pseudoaneurysm due to stent fracture

21 Jul 2021

View the case of an 85-year-old frail woman with end-stage renal disease, renal replacement therapy, and paroxysmal atrial fibrillation...

Unusual, late presentation of coronary pseudoaneurysm due to stent fracture

PCRonline @ ESC Congress 2021: the interventional cardiology perspective!

21 Jul 2021

Make sure you stay up to date with what's new and hot in interventional cardiology at this year's #ESCCongress!

PCRonline @ ESC Congress 2021

EuroPCR 2021 Hotlines / Late-Breaking Trials: Alster-FLX, ANGIE, COLOR, CREDENCE BRS, and P3

27 May 2021 – From EuroPCR 2021

Find out more about various studies & registries:

  • Left atrial appendage occlusion with the WATCHMAN FLX: The Alster-FLX Registry
  • Anatomical snuffbox for coronary angiography and interventions
  • Randomized comparison between Radial and Femoral Large-bore access Complex PCI
  • Experience with BRS for treatment of de novo native peripheral artery lesions
  • Clinical validation of...
EuroPCR 2021 Hotlines / Late-Breaking Trials: Alster-FLX, ANGIE, COLOR, CREDENCE BRS, and P3

EuroPCR 2021 Hotlines / Late-Breaking Trials in imaging: CASTLE, CLI-OPCI, FORZA, ILUMIEN-IV, CLI-OPCI II, and more!

27 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in imaging:

  • A randomized study comparing imaging guided implantation of Orsiro and Xience: the CASTLE study
  • Impact of different optimal stent implantation definitions in OCT-guide PCI
  • Risk-stratification in ACS by comprehensive morphofunctional assessment with OCT
  • 7.5 years follow-up after OCT-guided PCI: report...
EuroPCR 2021 Hotlines / Late-Breaking Trials in imaging: CASTLE, CLI-OPCI, FORZA, ILUMIEN-IV, CLI-OPCI II, and more!

EuroPCR 2021 Hotlines / Late-Breaking Trials: CENTURY JSV, SORT OUT IX, OUTDES, Epic02-RANGO, PIONEER III, and more!

26 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in stents:

  • First machine learning derived risk score for target lesion failure
  • Ultrathin versus Conventional Second-Generation DES: Meta-Analysis of RCTs
  • Five-year outcomes after coronary stenting of small vessels - CENTURY JSV study
  • 2-year outcomes of the randomized SORT OUT IX Trial
  • Outcomes of...
EuroPCR 2021 Hotlines / Late-Breaking Trials: CENTURY JSV, SORT OUT IX, OUTDES, Epic02-RANGO, PIONEER III, and more!